Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

被引：0
|
作者：
Yoshiteru Takekita
Yosuke Koshikawa
Chiara Fabbri
Shiho Sakai
Naotaka Sunada
Ai Onohara
Keiichiro Nishida
Masafumi Yoshimura
Masaki Kato
Alessandro Serretti
Toshihiko Kinoshita
机构：
[1] University of Bologna,Department of Biomedical and NeuroMotor Sciences
[2] Kansai Medical University,Department of Neuropsychiatry
来源：
BMC Psychiatry | / 16卷
关键词：
Schizophrenia; Risperidone long-acting injection; Paliperidone palmitate; Cognitive function; Efficacy; Subjective well-being;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Gaebel, Wolfgang
    Schreiner, Andreas
    Bergmans, Paul
    de Arce, Rosario
    Rouillon, Frederic
    Cordes, Joachim
    Eriksson, Lars
    Smeraldi, Enrico
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (12) : 2367 - 2377
  • [22] Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer K.
    Ma, Yi-Wen
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (01) : 45 - 55
  • [23] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Wolfgang Gaebel
    Andreas Schreiner
    Paul Bergmans
    Rosario de Arce
    Frédéric Rouillon
    Joachim Cordes
    Lars Eriksson
    Enrico Smeraldi
    Neuropsychopharmacology, 2010, 35 : 2367 - 2377
  • [24] A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
    Najarian, Dean
    Sanga, Panna
    Wang, Steven
    Lim, Pilar
    Singh, Arun
    Robertson, Mary Jane
    Cohen, Kristin
    Schotte, Alain
    Milz, Ruth
    Venkatasubramanian, Raja
    T'Jollyn, Huybrecht
    Walling, David P.
    Galderisi, Silvana
    Gopal, Srihari
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (03): : 238 - 251
  • [25] BASELINE DEMOGRAPHICS AND CLINICAL CHARACTERISTICS FROM A PROSPECTIVE, RANDOMIZED, OPEN-LABEL STUDY OF PALIPERIDONE PALMITATE LONG-ACTING INJECTION IN SUBJECTS WITH RECENT-ONSET SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
    Brown, Brianne
    Turkoz, Ibrahim
    Yue, Yong
    Alphs, Larry
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S117 - S117
  • [26] Erratum: Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Wolfgang Gaebel
    Andreas Schreiner
    Paul Bergmans
    Rosario de Arce
    Frédéric Rouillon
    Joachim Cordes
    Lars Eriksson
    Enrico Smeraldi
    Neuropsychopharmacology, 2011, 36 : 548 - 548
  • [27] Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study
    Detke, H.
    Weiden, P. J.
    Lambert, T.
    Llorca, P. M.
    Choukour, M.
    Watson, S. B.
    Brunner, E.
    Ascher-Svanum, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S464 - S464
  • [28] A randomized, double-blind study of flexible doses of paliperidone palmitate and risperidone long-acting therapy in patients with schizophrenia
    Pandina, G.
    Lane, R.
    Gopal, S.
    Gassmann-Mayer, C.
    Hough, D.
    Remmerie, B.
    Simpson, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
  • [29] RELAPSE PREVENTION WITH RISPERIDONE LONG-ACTING INJECTABLE VS. ORAL QUETIAPINE. RESULTS OF AN OPEN-LABEL RCT
    Gaebel, Wolfgang
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S5 - S5
  • [30] A Randomized, Double-Blind, Study of Flexible Doses of Paliperidone Palmitate and Risperidone Long-Acting Therapy in Patients with Schizophrenia
    Pandina, Gahan
    Lane, Rosanne
    Gopal, Srihari
    Gassman-Mayer, Cristiana
    Hough, David
    Remmerie, Bart
    Simpson, George
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 77S - +
12345